Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 137 citing articles:

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 3, pp. 606-638
Open Access | Times Cited: 601
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Wolfgang Löscher, Pavel Klein
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 935-963
Open Access | Times Cited: 210
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
Antonella Fattorusso, Sara Matricardi, Elisabetta Mencaroni, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 187
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 147
The metabolic basis of epilepsy
Jong M. Rho, Detlev Boison
Nature Reviews Neurology (2022) Vol. 18, Iss. 6, pp. 333-347
Closed Access | Times Cited: 146
The importance of sulfur-containing motifs in drug design and discovery
Muhamad Mustafa, Jean‐Yves Winum
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 5, pp. 501-512
Closed Access | Times Cited: 120
New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 24
Status of peripheral sodium channel blockers for non-addictive pain treatment
Matthew Alsaloum, Grant P. Higerd‐Rusli, Philip R. Effraim, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 12, pp. 689-705
Closed Access | Times Cited: 128
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
Yi Wang, Chen Zhong
Pharmacology & Therapeutics (2019) Vol. 201, pp. 77-93
Closed Access | Times Cited: 126
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca, Meir Bialer
CNS Drugs (2020) Vol. 34, Iss. 8, pp. 795-800
Closed Access | Times Cited: 124
Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects
Cecilie Johannessen Landmark, Svein I. Johannessen, Philip N. Patsalos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 3, pp. 227-238
Closed Access | Times Cited: 123
Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
Luis Felipe Santos Menezes, Elias Ferreira Sabiá Júnior, Diogo Vieira Tibery, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 107
Identifying mutations in epilepsy genes: Impact on treatment selection
Piero Perucca, Emilio Perucca
Epilepsy Research (2019) Vol. 152, pp. 18-30
Closed Access | Times Cited: 105
Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision Therapy
Allan Bayat, Michael Bayat, Guido Rubboli, et al.
Genes (2021) Vol. 12, Iss. 7, pp. 1051-1051
Open Access | Times Cited: 71
GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Rok Cerne, Arnold S. Lippa, Michael M. Poe, et al.
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108035-108035
Open Access | Times Cited: 71
The pharmacological treatment of epilepsy: recent advances and future perspectives
Emilio Perucca
Acta Epileptologica (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 62
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
Irina A. Pikuleva, Nathalie Cartier
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 60
Modelling epilepsy in the mouse: challenges and solutions
Grant F. Marshall, Alfredo Gonzalez-Sulser, Catherine M. Abbott
Disease Models & Mechanisms (2021) Vol. 14, Iss. 3
Open Access | Times Cited: 57
Serotonin receptors in epilepsy: Novel treatment targets?
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 39
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
Emilio Perucca, Meir Bialer, H. Steve White
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 755-779
Open Access | Times Cited: 39
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
Tingting Hu, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4434-4467
Closed Access | Times Cited: 29
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development
Emilio Perucca, H. Steve White, Meir Bialer
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 781-795
Open Access | Times Cited: 23
Established and emerging GABAA receptor pharmacotherapy for epilepsy
Robert J. Richardson, Steven Petrou, Alexander Bryson
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2858-2882
Open Access | Times Cited: 8
Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review
Rafael G. dos Santos, Jaime E. C. Hallak, José Alexandre S. Crippa
Advances in experimental medicine and biology (2020), pp. 29-45
Closed Access | Times Cited: 68
Page 1 - Next Page

Scroll to top